John Strasswimmer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
John Strasswimmer has a total of 213 co-authors. Here are the top co-authors by number of shared publications:
Audrey A. Jacobsen
University of Miami Miller School of Medicine, Florida
7 shared publications- Arthur Harry Macleod Burghes
Department of Neurology, Neuromuscular Division, The Ohio State University Wexner Medical Center, Columbus, USA
3 shared publications B. Hyle Park
3 shared publications- Barry Cense
Optical + Biomedical Engineering Laboratory, Department of Electrical, Electronic and Computer Engineering, The University of Western Australia, Perth, WA 6009, Australia
3 shared publications - Elliot J. Androphy
Department of Dermatology, Indiana University School of Medicine
3 shared publications Emily Poon
Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
3 shared publications
Latest Publications
- Open Access
- 29 May 2026
- Published by Elsevier in JAAD Case Reports
- Vol. 74, 215-217
Acute mucocutaneous syndrome and hemophagocytic lymphohistiocytosis following COVID-19 with prominent emperipolesis
- 29 May 2026
- Published by Elsevier in JAAD Case Reports
- Vol. 74, 215-217
Open AccessAcute mucocutaneous syndrome and hemophagocytic lymphohistiocytosis following COVID-19 with prominent emperipolesis
- 11 March 2026
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 95 (1) , 338-339
Melanoma outcome disparities in minority populations and the need for inclusive clinical trials for the benefit of all
- 11 March 2026
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 95 (1) , 338-339
Melanoma outcome disparities in minority populations and the need for inclusive clinical trials for the benefit of all
- Open Access
- 11 October 2025
- Published by Elsevier in JAAD International
- Vol. 24, 90-91
Neoadjuvant cemiplimab to facilitate Mohs micrographic surgery tumor extirpation and reduce surgical morbidity
- 11 October 2025
- Published by Elsevier in JAAD International
- Vol. 24, 90-91
Open AccessNeoadjuvant cemiplimab to facilitate Mohs micrographic surgery tumor extirpation and reduce surgical morbidity
- Open Access
- 14 May 2024
- Published by Elsevier in JAAD Case Reports
- Vol. 64, 7-9
Twelve-year continuous therapy with vismodegib for advanced basal cell carcinoma: Tolerability and partial reversibility of adverse events
- 14 May 2024
- Published by Elsevier in JAAD Case Reports
- Vol. 64, 7-9
Open AccessTwelve-year continuous therapy with vismodegib for advanced basal cell carcinoma: Tolerability and partial reversibility of adverse events
- Open Access
- 20 June 2023
- Published by Elsevier in JAAD Case Reports
- Vol. 38, 152-154
Optimizing the pharmacokinetics of sonidegib in small bowel syndrome and advanced basal cell carcinoma: Our solution
- 20 June 2023
- Published by Elsevier in JAAD Case Reports
- Vol. 38, 152-154
Open AccessOptimizing the pharmacokinetics of sonidegib in small bowel syndrome and advanced basal cell carcinoma: Our solution
- Open Access
- 6 June 2022
- Published by Elsevier in JAAD Case Reports
- Vol. 26, 53-56
Rapid response to cemiplimab for advanced cutaneous squamous cell carcinoma
- 6 June 2022
- Published by Elsevier in JAAD Case Reports
- Vol. 26, 53-56
Open AccessRapid response to cemiplimab for advanced cutaneous squamous cell carcinoma
- Open Access
- 1 October 2021
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 85 (4) , 1004-1006
Healthy skin for everyone: Long-term effectiveness of a multicomponent, community-based skin cancer intervention program for an underserved Hispanic population
- 1 October 2021
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 85 (4) , 1004-1006
Open AccessHealthy skin for everyone: Long-term effectiveness of a multicomponent, community-based skin cancer intervention program for an underserved Hispanic population
- 1 July 2020
- Published by Elsevier in Brachytherapy
- Vol. 19 (4) , 415-426
The American Brachytherapy society consensus statement for skin brachytherapy
- 1 July 2020
- Published by Elsevier in Brachytherapy
- Vol. 19 (4) , 415-426
The American Brachytherapy society consensus statement for skin brachytherapy
- 1 September 2019
- Vol. 12 (9) , 36-38
Lupus Erythematosus Lichen Planus Overlap Syndrome Mimicking Squamous Cell Carcinoma.
Lupus erythematosus lichen planus (LE-LP) overlap syndrome remains an uncommon diagnostic entity, combining both the histologic and clinical features of lupus erythematosus and lichen planus. A rare and challenging diagnosis, clinicopathologic correlation is essential for accurate and timely identification. Histologically, superficial evaluation of lupus erythematosus lichen planus overlap syndrome can mimic squamous cell carcinoma due to the presence of squamatized keratinocytes with concomitant irregular acanthosis. Here, we present a case of LE-LP overlap syndrome in a patient with long standing systemic lupus erythematosus initially misdiagnosed as squamous cell carcinoma.
- 1 September 2019
- Vol. 12 (9) , 36-38
Lupus Erythematosus Lichen Planus Overlap Syndrome Mimicking Squamous Cell Carcinoma.
Lupus erythematosus lichen planus (LE-LP) overlap syndrome remains an uncommon diagnostic entity, combining both the histologic and clinical features of lupus erythematosus and lichen planus. A rare and challenging diagnosis, clinicopathologic correlation is essential for accurate and timely identification. Histologically, superficial evaluation of lupus erythematosus lichen planus overlap syndrome can mimic squamous cell carcinoma due to the presence of squamatized keratinocytes with concomitant irregular acanthosis. Here, we present a case of LE-LP overlap syndrome in a patient with long standing systemic lupus erythematosus initially misdiagnosed as squamous cell carcinoma.
- 1 April 2017
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 76 (4) , 767-768
Practical management of the adverse effects of Hedgehog pathway inhibitor therapy for basal cell carcinoma
- 1 April 2017
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 76 (4) , 767-768
Practical management of the adverse effects of Hedgehog pathway inhibitor therapy for basal cell carcinoma